These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26229121)

  • 1. Prodding the Beast: Assessing the Impact of Treatment-Induced Metastasis.
    Ebos JM
    Cancer Res; 2015 Sep; 75(17):3427-35. PubMed ID: 26229121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The host immunological response to cancer therapy: An emerging concept in tumor biology.
    Voloshin T; Voest EE; Shaked Y
    Exp Cell Res; 2013 Jul; 319(11):1687-95. PubMed ID: 23518388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets.
    Nienhuis HH; Gaykema SB; Timmer-Bosscha H; Jalving M; Brouwers AH; Lub-de Hooge MN; van der Vegt B; Overmoyer B; de Vries EG; Schröder CP
    Pharmacol Ther; 2015 Mar; 147():63-79. PubMed ID: 25444756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the new biology for therapy in breast cancer.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions that induce modifications in the tumor microenvironment.
    Bernhard EJ
    Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regorafenib in metastatic colorectal cancer.
    Sartore-Bianchi A; Zeppellini A; Amatu A; Ricotta R; Bencardino K; Siena S
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):255-65. PubMed ID: 24559322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment.
    Kuonen F; Secondini C; Rüegg C
    Clin Cancer Res; 2012 Oct; 18(19):5196-202. PubMed ID: 22730447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel targeted agents in the treatment of multiple myeloma.
    Varga C; Laubach J; Hideshima T; Chauhan D; Anderson KC; Richardson PG
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):903-25. PubMed ID: 25212889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention.
    Bruno A; Pagani A; Magnani E; Rossi T; Noonan DM; Cantelmo AR; Albini A
    Cancer Treat Res; 2014; 159():401-26. PubMed ID: 24114493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antiangiogenic therapy and radiation in head and neck cancers.
    Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
    Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation treatment and cancer stem cells.
    Suh Y; Lee SJ
    Arch Pharm Res; 2015 Mar; 38(3):408-13. PubMed ID: 25620212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the mechanisms of organ-specific breast cancer metastasis.
    Lorusso G; Rüegg C
    Semin Cancer Biol; 2012 Jun; 22(3):226-33. PubMed ID: 22504658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast-mediated drug resistance in cancer.
    Paraiso KH; Smalley KS
    Biochem Pharmacol; 2013 Apr; 85(8):1033-41. PubMed ID: 23376122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the mechanisms of action of antiangiogenic agents in metastatic colorectal cancer: a clinician's perspective.
    Clarke JM; Hurwitz HI; Rangwala F
    Cancer Treat Rev; 2014 Oct; 40(9):1065-72. PubMed ID: 25047778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.
    Takano S
    Brain Tumor Pathol; 2012 Apr; 29(2):73-86. PubMed ID: 22218709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular targeting therapy: potential benefit depends on tumor and host related effects.
    Horsman MR; Bohn AB; Busk M
    Exp Oncol; 2010 Sep; 32(3):143-8. PubMed ID: 21403608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.